Handok joins up with Orient Europharma over Loramyc
Published: 2008-12-31 06:56:00
Updated: 2008-12-31 06:56:00
Handok Pharmaceuticals announced on December 24 that it has signed a licensing agreement with Taiwan’s Orient Europharma Co. Ltd. for the exclusive distribution rights in Taiwan, Singapore and Malaysia of Loramyc mucoadhesive buccal tablets.
Loramyc (miconazole lauriad) was developed by France...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.